MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Michelle Galeas-Pena(Tulane University), Sarah C. Glover(Tulane University), Tanya O. Robinson(University of Mississippi Medical Center), Sangita Sutradhar(University of Pennsylvania), Anna H. Owings(Unknown), Liza Konnikova(Yale University), Neha S. Dhaliwal(University of Mississippi Medical Center), Steve Everman(University of Mississippi Medical Center), Hydar Ali, Katelyn White(Tulane University), Alexander Carlye(University of Mississippi Medical Center), Dhana Llivichuzhca-Loja(Yale University), Ghina Yaghi(Tulane University), Jonathan J. Lyons(University of California San Diego)
Cited by 0
Related Papers
Individual intestinal symbionts induce a distinct population of RORγ <sup>+</sup> regulatory T cells
|Science|2015|886
Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
|Clinical Gastroenterology and Hepatology|2012|492
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
|Nature Genetics|2016|393